KUALA LUMPUR, Feb 22
(Bernama) -- Biotechnology company, Taconic Biosciences, has
announced the formation of its Scientific Advisory Board (SAB) with the initial
appointments of Dr J. Victor Garcia, Dr Andrew Goodman and Dr David Hill.
The SAB will collaborate with Taconic's management in providing scientific insight and guidance on the evolution of the company's product and service portfolios.
As Taconic is currently leading the microbiome and immuno-oncology spaces, the SAB members bring complementary expertise to continue to drive innovation in these and other research areas.
Chief Executive Officer of Taconic Biosciences, Bob Rosenthal said discovery and pre-clinical animal models continued to move toward highly-complex and high-value translational models.
"To continue to provide the best solutions for our customers, it is essential for Taconic to have guidance from prominent scientific experts as we develop and validate new models and services," he added.
Dr Garcia is a Professor of Medicine at the Center for AIDS Research (CFAR). He is an Oliver Smithies Investigator and fellow of the American Academy of Microbiology.
Dr Goodman is an Associate Professor of Microbial Pathogenesis and a member of the Microbial Sciences Institute at Yale University School of Medicine.
Dr Hill has a successful and extensive career leading the pharmacology departments of many major pharmaceutical companies, including a combined 20 years at Organon and Merck.
-- BERNAMA
No comments:
Post a Comment